Efficacy of Epstein-Barr virus removal by leukoreduction of red blood cells

Transfusion

Volumn 45, Issue 4, 2005, Pages 591-595

  Qu, Lirong ^a   Xu, Shushen ^b   Rowe, David ^b   Triulzi, Darrell ^b  

^a INSTITUTE FOR TRANSFUSION MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; BLOOD DONOR; BLOOD FILTRATION; CELL FRACTIONATION; EPSTEIN BARR VIRUS; ERYTHROCYTE; HUMAN; HUMAN TISSUE; LEUKOREDUCTION; MONONUCLEAR CELL; REAL TIME POLYMERASE CHAIN REACTION; VIRUS CARRIER; VIRUS GENOME;

ANTIGENS, CD19; B-LYMPHOCYTES; EPSTEIN-BARR VIRUS INFECTIONS; ERYTHROCYTES; GENE DOSAGE; HERPESVIRUS 4, HUMAN; HUMANS; LEUKOCYTE REDUCTION PROCEDURES;

EID: 17044376658     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0041-1132.2005.04303.x     Document Type: Article

References (24)

1. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994;77:791-3.
2. Rowe DT, Webber S, Schauer EM, Reyes J, Green M. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis 2001;3:79-87.
3. Qu L, Rowe DT. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J Virol 1992;66:3715-24.
4. Wagner HJ, Bein G, Bitsch A, Kirchner H. Detection and quantitation of latently infected B lymphocytes in Epstein-Barr virus sero-positive, healthy individuals by polymerase chain reaction. J Clin Microbiol 1992;30:2826-9.
5. Rowe DT, Qu L, Reyes J, et al. Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbol 1997;35:1612-5.
6. Miyashita E, Yang B, Babcock G, Thorley-Lawson D. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 1997;71:4882-91.
7. Babcock GJ, Decker LL, Volk M, Thorley-Lawson D. EBV persistence in memory B cells in vivo. Immunity 1998;9:395-404.
8. Alfieri C, Tanner J, Carpertier L, Perpete C, et al. Epstein-Barr virus transmission from a blood donor to an organ transplant recipient with recovery of the same virus strain from the recipient's blood and oropharynx. Blood 1996;87:812-7.
9. Tattevin P, Crémieux AC, Descamp D, Carbon C. Transfusion-related infectious mononucleosis. Scand J Infect Dis 2002;34:777-8.
10. Solem JH, Jörgensen W. Accidentally transmitted infectious mononucleosis. Acta Med Scand 1969;186:433-7.
11. Turner AR, McDonald RN, Cooper BA. Transmission of infectious mononucleosis by transfusion of pre-illness blood. Ann Intern Med 1972;77:751-3.
12. Gerber P, Walsh JH, Roseblum EN, Purcell RH. Association of EB-virus with the post-perfusion syndrome. Lancet 1969;1:593-6.
13. Henle W, Henle G. Epstein-Barr virus and blood transfusions. In: Dodd RY, Barker LF, eds. Infection, immunity, and blood transfusion. Proceedings of the XVith Annual Scientific Symposium of the American Red Cross. New York: A.R. Liss; 1995. p. 201-9.
14. Laupacis A, Brown J, Costello B, Delage G, et al. Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement. Transfusion 2001;41:560-9.
15. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
16. Lawrence JB, Villnave CA, Singer RH. Sensitive, high-resolution chromatin and chromosome mapping in situ, presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 1988;52:51-61.
17. Holub M, Kluckova Z, Helcl M, et al. Lymphocyte subset numbers depend on the bacterial origin of sepsis. Clin Microbiol Infect 2003;9:202-11.
18. Storek J, Monja A, Maloney DG. Normal T, B and NK cell counts in healthy donors at I year after blood stem cell harvesting. Blood 2000;95:2993-4.
19. Sitki-Green D, Covington M, Raab-Traub N. Compartmentalization and transmission of multiple Epstein-Barr virus strains in asymptomatic carriers. J Virol 2003;77:1840-7.
20. Walling DM, Brown AL, Etienne W, Keitel WA, Ling PD. Multiple Epstein-Barr virus infections in healthy individuals. J Virol 2003;77:6546-50.
21. Césaire R, Kérob-Bauchet B, Bourdonné O, et al. Evaluation of HTLV-1 removal by filtration of blood cell components in a routine setting. Transfusion 2004;44:42-8.
22. Vinconti MR, Pennington J, Garner SF, Allain JP, Williamson LM. Assessment of removal of human cytomegalovirus from blood components by leukocyte depletion filters using real-time quantitative PCR. Blood 2004;103:1137-9.
23. Wagner HJ, Klüter H, Kruse A, Bucsky P, et al. Determination of the number of Epstein-Barr virus genomes in whole blood and red cell concentrates. Transfus Med 1995;5:297-302.
24. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004;350:2461-70.